Focused on Liver Cancer Innovation Dr. Jeff Geschwind, MD, is at the forefront of liver cancer treatment. His collaborations with companies like HistoSonics are dedicated to advancing ablation technologies that offer effective, less invasive options for patients. https://jeffgeschwind.com/contact/